Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Eisai Co., Ltd.
Scientific Title
A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer